Status:
RECRUITING
A Weight Management Intervention for Overweight Chinese Cancer Survivors
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Health and Medical Research Fund
Conditions:
Cancer
Weight Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to conduct a feasibility trial to examine the feasibility and acceptability of conducting a randomized controlled trial that evaluates the effect of the weight management intervention ...
Detailed Description
The primary aim of the proposed study is to assess the feasibility and acceptability of conducting a randomized controlled trial (RCT) that evaluates an adaptive weight management intervention, tailor...
Eligibility Criteria
Inclusion
- Chinese cancer survivors attending the one-off face-to-face survivorship care clinic
- who are Cantonese- or Mandarin- speaking
- aged 18 or above
- diagnosed with early-stage disease (stage 0-II)
- have completed primary and adjuvant treatments such as chemotherapy and radiotherapy
- and with a BMI ≥ 23 kg/m2, as indicative as overweight or obesity using Asia-Pacific BMI cutoffs at 3-months reassessment
Exclusion
- Non-Chinese survivors with advanced or metastatic disease
- who have communication difficulties, mobility impairment or cognitive disabilities
Key Trial Info
Start Date :
October 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06209996
Start Date
October 31 2024
End Date
June 30 2026
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong Jockey Club Institute of Cancer Care
Hong Kong, Hong Kong